Table 3. Relationship of TRIM6 overexpression to the markers of immune cells in LUAD tissues from the ENCORI database.
| Cell type | Markers | r | p |
|---|---|---|---|
| CD8+ T cell | CD8A | 0.106 | 0.0146 |
| CD8B | 0.006 | 0.9 | |
| Macrophage | INOS (NOS2) | –0.024 | 0.582 |
| IRF5 | 0.143 | 0.001 | |
| COX2 (PTGS2) | 0.041 | 0.348 | |
| CD163 | 0.15 | 5.46e-4 | |
| VSIG4 | 0.123 | 4.81e-3 | |
| MS4A4A | 0.124 | 4.42e-3 | |
| Neutrophil | CD66b (CEACAM8) | 0.039 | 0.372 |
| CD11b (ITGAM) | 0.135 | 1.97e-03 | |
| Dendritic cell | HLA-DPB1 | 0.05 | 0.254 |
| HLA-DQB1 | 0.052 | 0.23 | |
| HLA-DRA | 0.084 | 0.0545 | |
| HLA-DPA1 | 0.107 | 0.0137 | |
| BDCA-1 (CD1C) | –0.024 | 0.577 | |
| BDCA-4 (NRP1) | 0.178 | 4.05e-5 | |
| CD11c (ITGAX) | 0.107 | 0.0144 |
TRIM6, tripartite motif containing 6; LUAD, lung adenocarcinoma.